List of Tables

Table 1. Parenteral Dosage Form Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Parenteral Dosage Form Market Restraints

Table 3. Parenteral Dosage Form Market Trends

Table 4. Parenteral Dosage Form Industry Policy

Table 5. Global Parenteral Dosage Form Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Parenteral Dosage Form Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Parenteral Dosage Form Sales Quantity by Company, (2020-2025) & (Kiloton), Ranked Based on Sales in 2024

Table 8. Global Parenteral Dosage Form Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Parenteral Dosage Form Average Selling Price (ASP) by Company, (2020-2025) & (US$/Ton)

Table 10. Global Parenteral Dosage Form Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Parenteral Dosage Form Mergers & Acquisitions, Expansion Plans

Table 12. Global Parenteral Dosage Form Manufacturers Product Type

Table 13. Head Office and Parenteral Dosage Form Production Site of Key Manufacturer

Table 14. Parenteral Dosage Form Capacity of Major Manufacturers and Future Plan

Table 15. China Parenteral Dosage Form Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Parenteral Dosage Form Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Parenteral Dosage Form Sales Quantity by Company, (2020-2025) & (Kiloton), Ranked Based on Sales in 2024

Table 18. China Parenteral Dosage Form Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Parenteral Dosage Form Production & Forecast by Region, 2020 VS 2024 VS 2031, (Kiloton)

Table 20. Global Parenteral Dosage Form Production by Region, 2020-2025, (Kiloton)

Table 21. Global Parenteral Dosage Form Production Forecast by Region, 2026-2031, (Kiloton)

Table 22. Global Key Players of Parenteral Dosage Form Upstream (Raw Materials)

Table 23. Global Parenteral Dosage Form Typical Customers

Table 24. Parenteral Dosage Form Typical Distributors

Table 25. by Type, Global Parenteral Dosage Form Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Parenteral Dosage Form Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Parenteral Dosage Form Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Parenteral Dosage Form Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Table 30. By Country, Global Parenteral Dosage Form Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Parenteral Dosage Form Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Parenteral Dosage Form Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Table 34. By Country, Global Parenteral Dosage Form Sales Quantity Market Share, 2020-2031

Table 35. Ashland Company Information, Head Office, Market Area, and Industry Position

Table 36. Ashland Parenteral Dosage Form Models, Specifications, and Application

Table 37. Ashland Parenteral Dosage Form Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 38. Ashland Company Profile and Main Business

Table 39. Ashland Recent Developments

Table 40. Tepnel Pharma Services Company Information, Head Office, Market Area, and Industry Position

Table 41. Tepnel Pharma Services Parenteral Dosage Form Models, Specifications, and Application

Table 42. Tepnel Pharma Services Parenteral Dosage Form Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 43. Tepnel Pharma Services Company Profile and Main Business

Table 44. Tepnel Pharma Services Recent Developments

Table 45. Ascendia Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Ascendia Pharmaceuticals Parenteral Dosage Form Models, Specifications, and Application

Table 47. Ascendia Pharmaceuticals Parenteral Dosage Form Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 48. Ascendia Pharmaceuticals Company Profile and Main Business

Table 49. Ascendia Pharmaceuticals Recent Developments

Table 50. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position

Table 51. Thermo Fisher Scientific Parenteral Dosage Form Models, Specifications, and Application

Table 52. Thermo Fisher Scientific Parenteral Dosage Form Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 53. Thermo Fisher Scientific Company Profile and Main Business

Table 54. Thermo Fisher Scientific Recent Developments

Table 55. ProJect Pharmaceutics Company Information, Head Office, Market Area, and Industry Position

Table 56. ProJect Pharmaceutics Parenteral Dosage Form Models, Specifications, and Application

Table 57. ProJect Pharmaceutics Parenteral Dosage Form Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 58. ProJect Pharmaceutics Company Profile and Main Business

Table 59. ProJect Pharmaceutics Recent Developments

Table 60. Lonza Company Information, Head Office, Market Area, and Industry Position

Table 61. Lonza Parenteral Dosage Form Models, Specifications, and Application

Table 62. Lonza Parenteral Dosage Form Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 63. Lonza Company Profile and Main Business

Table 64. Lonza Recent Developments

Table 65. BOC Sciences Company Information, Head Office, Market Area, and Industry Position

Table 66. BOC Sciences Parenteral Dosage Form Models, Specifications, and Application

Table 67. BOC Sciences Parenteral Dosage Form Sales Quantity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 68. BOC Sciences Company Profile and Main Business

Table 69. BOC Sciences Recent Developments

List of Figures

Figure 1. Parenteral Dosage Form Picture

Figure 2. Global Parenteral Dosage Form Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Parenteral Dosage Form Sales Quantity, (Kiloton) & (2020-2031)

Figure 4. Global Parenteral Dosage Form Average Selling Price (ASP), (2020-2031) & (US$/Ton)

Figure 5. China Parenteral Dosage Form Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Parenteral Dosage Form Sales Quantity (Kiloton) & (2020-2031)

Figure 7. China Parenteral Dosage Form Average Selling Price (ASP), (US$/Ton) & (2020-2031)

Figure 8. By Consumption Value, China Parenteral Dosage Form Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Parenteral Dosage Form Market Share of Global, 2020-2031

Figure 10. Global Parenteral Dosage Form Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Parenteral Dosage Form Key Participants, Market Share, 2024

Figure 12. Global Parenteral Dosage Form Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Parenteral Dosage Form Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Parenteral Dosage Form Production Market Share & Forecast by Region, 2020-2031

Figure 15. Parenteral Dosage Form Industry Chain

Figure 16. Parenteral Dosage Form Procurement Model

Figure 17. Parenteral Dosage Form Sales Model

Figure 18. Parenteral Dosage Form Sales Channels, Direct Sales, and Distribution

Figure 19. Emulsions for Injection

Figure 20. Powders for Injection

Figure 21. Gels for Injection

Figure 22. by Type, Global Parenteral Dosage Form Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Parenteral Dosage Form Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 25. by Type, Global Parenteral Dosage Form Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Parenteral Dosage Form Average Selling Price (ASP), 2020-2031, (US$/Ton)

Figure 27. Hospital

Figure 28. Clinic

Figure 29. Others

Figure 30. by Application, Global Parenteral Dosage Form Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Parenteral Dosage Form Revenue Market Share, 2020-2031

Figure 32. by Application, Global Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 33. by Application, Global Parenteral Dosage Form Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Parenteral Dosage Form Price, 2020-2031, (US$/Ton)

Figure 35. By Region, Global Parenteral Dosage Form Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Parenteral Dosage Form Sales Quantity Market Share, 2020-2031

Figure 37. North America Parenteral Dosage Form Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Parenteral Dosage Form Consumption Value Market Share, 2024

Figure 39. Europe Parenteral Dosage Form Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Parenteral Dosage Form Consumption Value Market Share, 2024

Figure 41. Asia Pacific Parenteral Dosage Form Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Parenteral Dosage Form Consumption Value Market Share, 2024

Figure 43. South America Parenteral Dosage Form Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Parenteral Dosage Form Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Parenteral Dosage Form Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 47. by Type, United States Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 50. by Type, Europe Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 53. by Type, China Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 56. by Type, Japan Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 59. by Type, South Korea Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 62. by Type, Southeast Asia Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 65. by Type, India Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Parenteral Dosage Form Sales Quantity, 2020-2031, (Kiloton)

Figure 68. by Type, Middle East & Africa Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Parenteral Dosage Form Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches